Survey on discount rates in biotech
What discount rates apply practitioners throughout the industry?
Avance and Biostrat conducted a survey about what discount rates practitioners use to value biotech companies. Due to the absence of a concise theory for the discount rate of early stage companies
E V E N T S
02/02/2011
Valuation in Biotech, 1h presentation
Basel - SWITZERLAND
03/03/2011 and 04/03/2011
License Contract and Company Valuation in Excel
Geneva - SWITZERLAND
P U B L I C A T I O N S
The effect of taxes on the value of start-up companies
Journal of Business Valuation and Economic Loss Analysis
Valuation in Life Sciences 3rd Edition
"Valuation in Life Sciences. A Practical Guide" has become the industry reference book. It has now been released already in its 3rd edition.
Discount by project or by company? (continued)
Why Santa Claus is wrong
In our last newsletter Santa Claus argued that we need to discount by company, because only this way we can capture the diversification effect between the projects. Well, in his line of thought there was a major mistake, even though the conclusion is not all wrong.
ri:val: Negotiate your deals with ri:val 4.1
ri:val has evolved from a valuation software to an important negotiation and planning tool. Clients from pharma, biotech, universities, and the investor community use ri:val to
MORE >
License Contract and Company Valuation:
2-day workshop in Geneva
Avance holds a 2-days' workshops on company valuation in Geneva. The first day will cover project and license valuation. On the second day we will touch company valuation with delicate topics like cost of capital, taxes, and Monte Carlo simulations. All topics will be put into practice with a case study in Excel.
You can sign up for News in Avance or change your e-mail address here.
[Abmeldelink]
Copyright: Avance, Basel GmbH - Bäumleingasse 2 - CH - 4051 Basel
